Intellikine LLC

États‑Unis d’Amérique

 
Quantité totale PI 42
Rang # Quantité totale PI 33 790
Note d'activité PI 1,4/5.0    5
Rang # Activité PI 197 981
Parent Millennium Pharmaceuticals, Inc.

Brevets

Marques

19 0
7 0
16 0
0
 
Dernier brevet 2025 - Certain chemical entities, compo...
Premier brevet 2008 - Certain chemical entities and th...

Derniers inventions, produits et services

2025 Invention Certain chemical entities, compositions and methods. Chemical entities that modulate PI3 kinase ...
2019 Invention Certain chemical entities, compositions and methods. Chemical entities that modulate PI3 kinase a...
2017 Invention Heterocyclic compounds and uses thereof. Heterocyclic entities that modulate PI3 kinase activity...
Invention Treatment regimens using multiple pharmaceutical agents. The present invention provides for meth...
2016 Invention Heterocyclic kinase inhibitors. Provided herein are compounds of formula (I-A), (I-B), (I-C), or ...
Invention Combination of mtor inhibitors and pi3-kinase inhibitors, and uses thereof. The present inventio...
2015 Invention Substituted isoquinolin-1(2h)-one compounds, compositions, and methods thereof. Chemical entities...
Invention Kinase inhibitors and methods of use. The present invention provides chemical entities or compoun...
Invention Benzothiazole kinase inhibitors and methods of use. The present invention provides chemical entit...
2014 Invention Combination of kinase inhibitors and uses thereof. The present invention provides for a method f...
2013 Invention Chemical entities and therapeutic uses thereof. Certain chemical entities that modulate PI3 kina...
Invention Treatment of polycystic disease. The present invention provides methods of treating polycystic d...
Invention Substituted isoquinolin-1(2h)-one compounds, compositions, and methods thereof. Substituted isoqu...
2012 Invention Enhanced treatment regimens using mtor inhibitors. The present invention provides for methods and...
Invention Enhanced treatment regimens using mtor inhibitors. Methods and pharmaceutical compositions compri...
Invention Combination of kinase inhibitors and uses thereof. The present invention provides for a method fo...
Invention Kinase inhibitor polymorphs. Polymorphs of chemical compounds that modulate kinase activity, incl...
Invention Treatment regimens using multiple pharmaceutical agents. The present invention provides for metho...
Invention Kinase inhibitor polymorphs. Polymorphs, hydrates, and solvates of chemical compounds that modula...
Invention Treatment of polycystic disease. The present invention provides methods of treating polycystic di...
Invention Reactive mtor and pi3 kinase inhibitors and uses thereof. The present invention provides for a co...
Invention Heterocyclic compounds and uses thereof. Heterocyclic entities that modulate PI3 kinase activity,...
Invention Combination of mtor inhibitors and p13-kinase inhibitors, and uses thereof. The present invention...